Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Bronchopulmonary Sequestration (BPS) is a rare congenital abnormality that affects the lungs and airways. It occurs when a portion of the lung develops abnormally during fetal development, resulting in a separate compartment or "sequestrum" that is not connected to the main airway. This sequestrum is surrounded by a membrane and contains blood vessels, air cells, and other structures found in normal lung tissue.

The symptoms of BPS can vary depending on the size and location of the sequestrum, but may include:

* Difficulty breathing (dyspnea)
* Coughing up blood (hemoptysis)
* Chest pain (toracalgia)
* Fatigue
* Shortness of breath (dyspnea)
* Recurrent respiratory infections

BPS can be diagnosed using imaging tests such as chest X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI). A lung biopsy may also be performed to confirm the diagnosis.

Treatment for BPS typically involves surgery to remove the sequestrum and repair any damage to the surrounding lung tissue. In some cases, surgery may not be possible or may not completely resolve the symptoms, in which case other treatments such as oxygen therapy, respiratory therapy, and medications may be used to manage the condition.

Overall, Bronchopulmonary Sequestration is a rare and complex congenital abnormality that requires careful evaluation and management by a team of medical professionals, including pulmonologists, surgeons, and other specialists. With appropriate treatment, many individuals with BPS can experience improved respiratory function and quality of life.

The term "hydrops" refers to the excessive accumulation of fluid in the body, and "fetalis" indicates that the condition occurs during fetal development. The condition is often diagnosed during the second or third trimester of pregnancy, and it can be associated with other congenital anomalies or genetic disorders.

The symptoms of hydrops fetalis can vary depending on the underlying cause, but they may include:

* Enlargement of the fetus
* Increased amniotic fluid levels
* Poor fetal growth
* Abnormalities in the ultrasound examination
* Premature birth or stillbirth

Hydrops fetalis is a serious condition that requires close monitoring and management by a multidisciplinary team of healthcare providers, including obstetricians, maternal-fetal medicine specialists, and perinatologists. Treatment options may include:

* Close monitoring of the pregnancy to detect any complications early
* Medications to help manage symptoms such as high blood pressure or heart failure
* Surgical interventions, such as amnioreduction or fetoscopy, to reduce fluid accumulation and improve fetal growth
* In some cases, delivery of the baby may be necessary, either through cesarean section or vaginal delivery.

The prognosis for hydrops fetalis is generally poor, with high rates of stillbirth and neonatal mortality. However, with early diagnosis and appropriate management, the outcome can be improved. It is important for pregnant women to seek medical attention immediately if they experience any symptoms or abnormalities that may indicate hydrops fetalis.

The exact cause of BPD is not fully understood, but it is thought to be related to a combination of genetic and environmental factors. Babies who are born prematurely or have low birth weights are at higher risk for developing BPD.

Symptoms of BPD can include rapid breathing, difficulty breathing, and bluish color of the skin (cyanosis). Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests.

There is no cure for BPD, but treatment options are available to help manage symptoms and improve lung function. These may include oxygen therapy, respiratory therapy, and medications such as bronchodilators or steroids. In severe cases, babies with BPD may require mechanical ventilation.

Long-term outcomes for babies with BPD can vary widely, depending on the severity of the disease and other individual factors. Some children may experience ongoing breathing problems and developmental delays, while others may recover fully with time. With appropriate treatment and support, however, many babies with BPD are able to lead healthy lives.

The prognosis for BPD is generally better for babies who are born at later gestational ages and have fewer other health problems. However, even with appropriate treatment, some babies with BPD may experience ongoing breathing difficulties and other complications throughout their lives. These may include:

* Respiratory infections: Babies with BPD are at higher risk for developing respiratory infections such as pneumonia, which can be serious and potentially life-threatening.
* Chronic lung disease: BPD can lead to long-term breathing problems and chronic lung disease, which can require ongoing medical treatment.
* Developmental delays: Babies with BPD may experience developmental delays and learning disabilities, particularly if they spent a significant amount of time in the neonatal intensive care unit (NICU).
* Behavioral and emotional problems: Some children with BPD may experience behavioral and emotional problems, such as anxiety and depression, which can be related to their medical history and experiences.

Overall, while babies with BPD face a higher risk for ongoing breathing problems and other complications, many are able to recover fully with appropriate treatment and support. It is important for parents and caregivers to work closely with healthcare providers to monitor their child's condition and address any ongoing concerns or complications.

The main cause of ABPA is exposure to airborne spores of the fungus Aspergillus, which are commonly found in soil and decaying organic matter. Individuals with a pre-existing allergic condition may be more susceptible to developing an allergic reaction to these spores, leading to inflammation and damage to the airways.

Diagnosis of ABPA typically involves a combination of physical examination, medical history, and diagnostic tests such as chest X-rays, CT scans, and bronchoscopy with biopsy. Treatment for ABPA typically involves corticosteroids to reduce inflammation and antifungal medications to treat any underlying infection. In severe cases, hospitalization may be necessary to provide oxygen therapy and other supportive care.

Prevention of ABPA includes avoiding exposure to known allergens and maintaining good respiratory hygiene. This can involve regularly cleaning and disinfecting surfaces and objects, using HEPA filters in air purifiers, and wearing a mask when working with or around potentially contaminated materials.

Prognosis for ABPA is generally good if treated promptly and effectively, but untreated cases can lead to serious complications such as respiratory failure and other organ damage. With proper management and prevention strategies in place, individuals with ABPA can lead active and fulfilling lives.

The symptoms of pulmonary embolism can vary, but may include shortness of breath, chest pain, coughing up blood, rapid heart rate, and fever. In some cases, the clot may be large enough to cause a pulmonary infarction (a " lung injury" caused by lack of oxygen), which can lead to respiratory failure and death.

Pulmonary embolism can be diagnosed with imaging tests such as chest X-rays, CT scans, and ultrasound. Treatment typically involves medications to dissolve the clot or prevent new ones from forming, and in some cases, surgery may be necessary to remove the clot.

Preventive measures include:

* Avoiding prolonged periods of immobility, such as during long-distance travel
* Exercising regularly to improve circulation
* Managing chronic conditions such as high blood pressure and cancer
* Taking blood-thinning medications to prevent clot formation

Early recognition and treatment of pulmonary embolism are critical to reduce the risk of complications and death.